- Home
- LGO vs INMB Comparison
LGO vs INMB Comparison
Compare LGO & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LGO | INMB |
|---|---|---|
| Founded | 1988 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.8M | 57.9M |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LGO | INMB |
|---|---|---|
| Price | $0.79 | $2.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $3.25 | ★ $5.40 |
| AVG Volume (30 Days) | ★ 550.0K | 345.9K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | $50.56 | N/A |
| Revenue Next Year | $59.94 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.55 | $1.09 |
| 52 Week High | $2.70 | $2.48 |
Technical Indicators
Market Signals| Indicator | LGO | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 56.88 | 72.96 |
| Support Level | $0.59 | $1.37 |
| Resistance Level | $0.83 | N/A |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 69.97 | 94.64 |
Price Performance
Historical ComparisonAbout LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.